JAMA Netw Open28 Aug 2024
Findings indicate that non-Hispanic Black patients with colon cancer treated at Commission on Cancer (CoC)-accredited hospitals received significantly more guideline-concordant care than those treated at non-accredited facilities. Specifically, the odds of undergoing necessary lymphadenectomy and chemotherapy were higher (adjusted odds ratios of 1.89 and 2.31,…
J Gastrointest Surg27 Aug 2024
Findings revealed that among Medicare patients undergoing colectomy for colon cancer, those in the highest social vulnerability quintile faced a greater likelihood of unplanned surgeries (35.6% vs. 28.9%) and higher 30-day (3.4% vs. 2.9%) and 1-year mortality rates (10.8% vs. 8.6%). The adjusted odds ratios…
Eur J Surg Oncol27 Aug 2024
A study of 3,020 stage III rectal cancer patients identified that 12.4% had a positive circumferential resection margin (CRM). Notably, CRM involvement predominantly occurred through primary tumor invasion (63.2%). Local recurrence and distant metastasis rates varied, being lowest with lymph node metastasis and highest with…
Int J Colorectal Dis26 Aug 2024
A nomogram was developed to predict postoperative complications in 207 patients with middle and low rectal cancer undergoing transanal total mesorectal excision (TATME). Findings indicated that 27.5% of patients experienced complications. Key predictors included operation time, smoking history, anastomotic technique, and ASA score, each significantly…
Intestine and Lower Gastrointestinal Tract26 Aug 2024
A systematic review and meta-analysis of six randomized trials, including 1949 patients, demonstrated that indocyanine green (ICG) fluorescence significantly reduces anastomotic leak rates in left-sided colorectal resections. The pooled odds ratio showed a 4.7% absolute reduction in leak rates (OR: 0.586, 95% CI: 0.434-0.792), indicating…
J Gastrointest Surg25 Aug 2024
Oral carbohydrate loading before elective colorectal surgery significantly reduces postoperative insulin resistance, inflammatory markers, and improves patient well-being. In a randomized controlled trial with 72 participants, the carbohydrate loading group showed a marked decrease in insulin resistance on the day of surgery and postoperatively. Additionally,…
J Gastrointest Surg25 Aug 2024
Among 339 patients with locally advanced rectal cancer, 208 (61.3%) completed total neoadjuvant therapy, achieving a final complete response (CR) rate of 42.3%. Notably, 57 patients (27.4%) sustained clinical CR for over a year, while 42 patients showed pathologic CR post-surgery. Predictors of CR included…
Int J Surg24 Aug 2024
In a multicenter study of 178 patients with mid-low rectal adenocarcinoma, 80.9% maintained rectal preservation after neoadjuvant treatment using either transanal local excision or a watch-and-wait approach. Overall survival at three years was 80.6%, while disease-free survival reached 97.6%. Local recurrence-free and distant recurrence-free survival…
Surg Endosc23 Aug 2024
A multicenter analysis revealed that robot-assisted pelvic exenteration (RPE) significantly reduces blood loss, transfusion rates, and postoperative complications compared to open (OPE) and laparoscopic pelvic exenteration (LPE). Specifically, RPE resulted in blood loss of 408 ml versus 2385 ml for OPE, with a transfusion rate…
Tech Coloproctol21 Aug 2024
In a phase II study involving 51 patients with pilonidal sinus (PNS), RD2 Ver.02 demonstrated significant results. Three months post-treatment, 82.4% achieved primary healing, increasing to 90.2% and 82.4% at six and twelve months, respectively. Recurrence occurred in 11.8% of patients within a year, while…